Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

3610

LikeLikedUnlike

571-585 of 962

GA Cases in the Primary Eye Care Clinic: Can You Spot the Three Signs?
CME/CE
GA Cases in the Primary Eye Care Clinic: Can You Spot the Three Signs?
- Yasha S. Modi, MD, MHS
  Peer
- Danny Mammo, MD
  Peer
0.25 credits
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
CME/CE
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
- Javier Cortes, MD, PhD
  Peer
- Hope S. Rugo, MD, FASCO
  Peer
0.50 credits
MinuteCE®
HER2-Expressing MBC In Depth: The Latest Advances in Targeted Therapies and Brain Metastases Management
- Carey Anders, MD, FASCO
  Peer
- Sarah Sammons, MD
  Peer
1.00 credits 10 episodes
Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
MinuteCE®
Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
- Carey Anders, MD, FASCO
  Peer
- Sarah Sammons, MD
  Peer
1.00 program credits
HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
MinuteCE®
HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
- Sarah Sammons, MD
  Peer
1.00 program credits
Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC
MinuteCE®
Leveraging Clinical Data: HER2-Targeted ADCs in Second-Line and Beyond MBC
- Carey Anders, MD, FASCO
  Peer
1.00 program credits
advertisement
Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC
MinuteCE®
Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC
- Sarah Sammons, MD
  Peer
- Carey Anders, MD, FASCO
  Peer
1.00 program credits
Understanding CNS Lesions in HER2+ Metastatic Breast Cancer
MinuteCE®
Understanding CNS Lesions in HER2+ Metastatic Breast Cancer
- Sarah Sammons, MD
  Peer
1.00 program credits
Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches
MinuteCE®
Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches
- Carey Anders, MD, FASCO
  Peer
1.00 program credits
Optimizing Treatment Selection for HER2+ Breast Cancer Patients with Brain Metastases
MinuteCE®
Optimizing Treatment Selection for HER2+ Breast Cancer Patients with Brain Metastases
- Carey Anders, MD, FASCO
  Peer
- Sarah Sammons, MD
  Peer
1.00 program credits
Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer
MinuteCE®
Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer
- Sarah Sammons, MD
  Peer
1.00 program credits
Emerging Data in HER2-Targeted ADCs for Metastatic Breast Cancer
MinuteCE®
Emerging Data in HER2-Targeted ADCs for Metastatic Breast Cancer
- Carey Anders, MD, FASCO
  Peer
1.00 program credits
advertisement
Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer
MinuteCE®
Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer
- Carey Anders, MD, FASCO
  Peer
- Sarah Sammons, MD
  Peer
1.00 program credits
Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care
CME/CE
Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care
- Heather McArthur, MD
  Peer
- Margaret Gatti-Mays, MD, MPH
  Peer
0.25 credits
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
CME/CE
Maximizing Myeloma Outcomes With GPRC5D-Directed Therapy: Practical Expert Case Studies and Best Practices
0.25 credits

Program Chapters

Segment Chapters

Playlist:

Recommended